V

Veracyte
D

VCYT

30.220
USD
0.18
(0.60%)
مغلق
حجم التداول
43,234
الربح لكل سهم
1
العائد الربحي
-
P/E
89
حجم السوق
2,377,455,389
أصول ذات صلة
A
ADPT
0.130
(1.01%)
13.040 USD
BMRN
BMRN
-0.470
(-0.81%)
57.530 USD
DXCM
DXCM
1.000
(1.25%)
80.980 USD
F
FATE
0.00000
(0.00%)
1.08000 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
R
RGEN
-2.350
(-1.86%)
124.320 USD
T
TDOC
0.23000
(3.15%)
7.52500 USD
VEEV
VEEV
5.57
(2.02%)
280.60 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.